Few signaling systems in human biology do as much with as little as the melanocortin system. A single gene produces one long precursor protein. Enzymes cut that precursor into a handful of short peptides. Those peptides act on a family of just five receptors. And yet the outputs span skin color, the stress-hormone axis, body weight, and sexual arousal — traits that seem to have nothing in common until you trace them back to the same molecular hardware.
For the research community, the melanocortin system is also where several catalog compounds actually live. Melanotan 1, Melanotan 2, and PT-141 are all melanocortin-receptor ligands, and understanding what separates them starts with understanding the system they plug into. This piece is the map. For a head-to-head on the two tanning peptides specifically, see the earlier Melanotan 1 vs Melanotan 2 comparison.
One gene, many messengers
The whole system begins with proopiomelanocortin (POMC), a precursor polypeptide transcribed from a single gene. On its own, POMC does almost nothing. Its biology is entirely a story of post-translational processing — the same molecule is cut into different final products depending on which cell is doing the cutting.
The scissors are a pair of enzymes, the prohormone convertases PC1/3 and PC2. In the corticotroph cells of the anterior pituitary, PC1/3 dominates and cleaves POMC mainly into ACTH (adrenocorticotropic hormone) and β-lipotropin. In the hypothalamus and the intermediate-lobe melanotrophs, PC2 goes further, snipping ACTH itself into α-MSH (alpha-melanocyte-stimulating hormone) and β-lipotropin into β-endorphin and β-MSH.
So one precursor yields a whole cast of signaling molecules: ACTH, α-MSH, β-MSH, γ-MSH, β-endorphin, and several fragments. The melanocortins proper are α-MSH, β-MSH, γ-MSH, and ACTH. (β-endorphin, cut from the same protein, is an opioid peptide that talks to a completely different receptor family — a reminder that shared origin does not mean shared target.)
α-MSH is worth a closer look because it is the workhorse melanocortin. Structurally it is simply the first 13 amino acids of ACTH — ACTH(1–13) — but capped: N-terminally acetylated and C-terminally amidated. Those small chemical caps sharpen its receptor activity and slow its breakdown. The core message it carries is a four-residue motif, His-Phe-Arg-Trp, the pharmacophore that virtually every melanocortin agonist is built around.
Five receptors on one switch
The melanocortins signal through five receptors, MC1R through MC5R. All five are class A G-protein-coupled receptors, and all five couple to the same downstream switch: Gs → adenylyl cyclase → cyclic AMP → protein kinase A. Bind a melanocortin, and the cell's cAMP rises. That is the shared grammar of the whole system.
What differs is not the switch but the wiring — which receptor sits on which tissue, and which peptides it will listen to:
- MC1R — melanocytes and immune cells. Governs the eumelanin/pheomelanin balance behind skin and hair pigment, and carries an anti-inflammatory signal in leukocytes.
- MC2R — adrenal cortex. The odd one out (more below).
- MC3R — hypothalamus and periphery. Involved in energy balance, feeding rhythm, and inflammation.
- MC4R — hypothalamus. A master node for appetite and energy expenditure, and a contributor to sexual function.
- MC5R — exocrine glands. Linked to sebaceous secretion and thermoregulation.
Because the receptors share a transduction pathway but differ in location and ligand preference, receptor selectivity is the single variable that determines what a given melanocortin ligand does in a research model. A compound that leans on MC1R reads out mostly as pigmentation; one that engages MC4R reads out in energy and sexual-behavior endpoints. That selectivity axis is exactly what the Melanotan comparison unpacks, so we keep the map brief here and turn to the parts of the system the tanning peptides never touch.
MC2R: the adrenal branch that only answers to ACTH
MC2R is the melanocortin receptor most researchers forget, and it is the most instructive. Sitting on the cells of the adrenal cortex, it is the receptor that ACTH activates to drive steroidogenesis — the synthesis of cortisol and adrenal androgens. In other words, one arm of the melanocortin family is the effector limb of the hypothalamic-pituitary-adrenal (HPA) stress axis.
Two features make MC2R unique. First, it is the only melanocortin receptor that does not respond to the MSH peptides at all — α-, β-, and γ-MSH cannot activate it. Only full-length ACTH will. This is why a broad MSH-type ligand does not switch on cortisol production the way ACTH does: the adrenal branch is functionally walled off from the MSH signal.
Second, MC2R cannot even reach the cell surface or function on its own. It requires a chaperone, the melanocortin-2-receptor accessory protein (MRAP), to traffic to the membrane and respond to ACTH. Loss-of-function mutations in either MC2R or MRAP cause familial glucocorticoid deficiency — living proof that this receptor is the non-negotiable relay between pituitary ACTH and adrenal cortisol.
For anyone reading the melanocortin literature, MC2R is the reminder that this system is not just about skin and appetite. It is threaded directly through the body's stress-hormone machinery.
A system with a built-in brake
Most receptor systems are switched off simply by removing the agonist. The melanocortin system is unusual: it ships with endogenous antagonists — molecules whose whole job is to actively oppose the melanocortins.
In the skin, agouti-signaling protein (ASIP) blocks MC1R. When ASIP is present, it pushes melanocytes away from dark eumelanin and toward reddish pheomelanin — the molecular basis of banded "agouti" fur coloring in mammals.
In the brain, the parallel molecule is agouti-related peptide (AgRP), which antagonizes MC3R and MC4R. AgRP does not merely block the receptors passively; it acts as an inverse agonist, pushing their baseline activity below resting levels. A neuroendocrine system with a dedicated inverse agonist is rare, and it tells you the melanocortin tone in the hypothalamus is meant to be actively pushed both up and down, not just switched on and off.
That push-pull is the key to the system's best-studied physiology.
The leptin–melanocortin satiety circuit
Zoom into the arcuate nucleus of the hypothalamus and you find two opposing populations of neurons wired into the same melanocortin output:
- POMC neurons, which release α-MSH to stimulate MC4R in the paraventricular nucleus — a satiety ("stop eating") signal.
- AgRP/NPY neurons, which release AgRP to block MC4R — a hunger ("keep eating") signal.
The fat-derived hormone leptin is the upstream referee. Rising leptin (a fed, energy-replete state) activates POMC neurons and suppresses AgRP neurons, tilting the balance toward α-MSH, MC4R activation, and satiety. Falling leptin (a fasted state) does the reverse: AgRP rises, MC4R is silenced, and appetite climbs. This leptin → POMC → α-MSH → MC4R relay is one of the most important energy-homeostasis circuits known.
Its importance is underscored by human genetics: loss-of-function mutations in MC4R are the most common single-gene cause of obesity, and mutations further upstream — in POMC itself, in the PC1/3 enzyme, or in the leptin receptor — produce severe early-onset obesity. The melanocortin system is not a peripheral curiosity; it is a central thermostat for body weight.
Where research compounds map onto the system
Because the pathway is so well mapped, it has become a validated drug target, and the approved agents are useful reference points for what each receptor branch can do when engaged. As pharmacology facts — not recommendations — three have reached the clinic:
- Afamelanotide (an α-MSH analog) has been developed and approved for photoprotection in erythropoietic protoporphyria, working through the MC1R/pigmentation branch.
- Bremelanotide has been approved for hypoactive sexual desire disorder in premenopausal women, acting on the MC4R branch.
- Setmelanotide has been approved for rare monogenic obesity (POMC, PCSK1, or leptin-receptor deficiency, and Bardet-Biedl syndrome), an MC4R agonist that restores signaling downstream of a broken upstream circuit.
Against that backdrop, the catalog ligands map cleanly. Melanotan 1 is the research counterpart most weighted toward MC1R and pigmentation endpoints. Melanotan 2 is a non-selective agonist that engages MC1R, MC3R, MC4R, and MC5R together. PT-141 is a Melanotan-2-derived fragment that lands preferentially on MC4R — the sexual-function branch — with far less pigmentation activity. Same system, three different receptor footprints, three different research profiles. For how those distinctions show up in identity and purity testing, see /quality/; for the broader compound reference set, /library/.
Frequently asked questions
Why does one precursor make so many different peptides? Because processing is tissue-specific. The PC1/3 and PC2 enzymes are expressed at different levels in different cells, so the same POMC protein is cut into ACTH in one tissue and further into α-MSH in another. The final product is set by the cell, not the gene.
Do all melanocortins hit all five receptors? No. The MSH peptides act across MC1R and MC3R–MC5R with differing potencies, but MC2R responds only to ACTH. Selectivity — and the MRAP requirement at MC2R — is what keeps the branches functionally separate.
Is the melanocortin system the same as the melatonin system? No, despite the similar names. Melatonin is an indoleamine hormone acting on MT1/MT2 receptors for circadian timing; melanocortins are peptides acting on MC1R–MC5R. The overlap is only in the "melano-" root referring to pigment.
This article is educational and for the laboratory research community. Trulogic Labs products are sold for laboratory and research use only and are not for human consumption.